Active ingredientCebranopadolCat. No. P-C064-001CAS 863513-91-1Family · Pharmaceutical analytical standards
Cebranopadol
An investigational analgesic that stimulates both the mu opioid receptor and the nociceptin (NOP) receptor, described in patents in the early 2000s and reaching phase 3 studies in acute and postoperative pain in the 2020s. This family brings together the active ingredient and other impurities.
Did you know?The NOP receptor was discovered before its natural ligand, nociceptin, which was identified only in 1995 by two independent groups: the first example of "reverse pharmacology".
Go to the active ingredient →Active ingredientCebranopadolCat. No. P-C064-001CAS 863513-91-1
Impurity2-(5-fluoro-1H-indol-3-yl)ethanolCat. No. P-C064-002CAS 101349-12-6
ImpurityCebranopadol Impurity 1Cat. No. P-C064-003CAS 1004541-42-7
ImpurityLexanopadolCat. No. P-C064-004CAS 1357348-09-4No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.